These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1753165)
21. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Branigan EF; Estes MA Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017 [TBL] [Abstract][Full Text] [Related]
22. Fertilization in vitro of supernumerary oocytes following gamete intra-fallopian transfer (GIFT). Critchlow JD; Matson PL; Troup SA; Ibrahim ZH; Burslem RW; Buck P; Lieberman BA Hum Reprod; 1990 Oct; 5(7):853-6. PubMed ID: 2125057 [TBL] [Abstract][Full Text] [Related]
23. Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intrafallopian transfer. Kubik CJ; Guzick DS; Berga SL; Zeleznik AJ Fertil Steril; 1990 Nov; 54(5):836-41. PubMed ID: 2121551 [TBL] [Abstract][Full Text] [Related]
24. Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization. Avrech OM; Orvieto R; Pinkas H; Sapir-Rufas O; Feldberg D; Fisch B Gynecol Endocrinol; 2004 Nov; 19(5):247-52. PubMed ID: 15726912 [TBL] [Abstract][Full Text] [Related]
25. Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT. Smitz J; Devroey P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC Hum Reprod; 1988 Oct; 3 Suppl 2():35-8. PubMed ID: 3147990 [TBL] [Abstract][Full Text] [Related]
26. High-order oocyte transfer in gamete intrafallopian transfer patients 40 or more years of age. Qasim SM; Karacan M; Corsan GH; Shelden R; Kemmann E Fertil Steril; 1995 Jul; 64(1):107-10. PubMed ID: 7789543 [TBL] [Abstract][Full Text] [Related]
27. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients. Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013 [TBL] [Abstract][Full Text] [Related]
28. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Chang MY; Chiang CH; Hsieh TT; Soong YK; Hsu KH Fertil Steril; 1998 Mar; 69(3):505-10. PubMed ID: 9531887 [TBL] [Abstract][Full Text] [Related]
29. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI]. Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229 [No Abstract] [Full Text] [Related]
30. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Craft I; Gorgy A; Hill J; Menon D; Podsiadly B Hum Reprod; 1999 Dec; 14(12):2959-62. PubMed ID: 10601078 [TBL] [Abstract][Full Text] [Related]
31. Gamete intra-Fallopian transfer or in-vitro fertilization after failed ovarian stimulation and intrauterine insemination in unexplained infertility? Ranieri M; Beckett VA; Marchant S; Kinis A; Serhal P Hum Reprod; 1995 Aug; 10(8):2023-6. PubMed ID: 8567835 [TBL] [Abstract][Full Text] [Related]
32. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Daya S Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664 [TBL] [Abstract][Full Text] [Related]
33. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487 [TBL] [Abstract][Full Text] [Related]
34. The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles. Owen EJ; Davies MC; Kingsland CR; Jacobs HS; Mason BA Hum Reprod; 1989 Oct; 4(7):749-53. PubMed ID: 2514192 [TBL] [Abstract][Full Text] [Related]
35. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist. Tanbo T; Dale PO; Abyholm T Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069 [TBL] [Abstract][Full Text] [Related]
36. Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a. Karacan M; Erkan H; Karabulut O; Sarikamiş B; Camlibel T; Benhabib M J Reprod Med; 2001 May; 46(5):485-9. PubMed ID: 11396377 [TBL] [Abstract][Full Text] [Related]
37. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Smitz J; Devroey P; Braeckmans P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC Hum Reprod; 1987 May; 2(4):309-14. PubMed ID: 3114314 [TBL] [Abstract][Full Text] [Related]
38. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435 [TBL] [Abstract][Full Text] [Related]
39. Induction of ovulation for gamete intrafallopian transfer (GIFT) using a gonadotropin-releasing hormone agonist and "pure" FSH: results obtained in 30 normally menstruating women. La Sala GB; Cantarelli M; Parolari G; Dessanti L; Dall'Asta D; Torelli MG; Salvatore V; Dotti C; Cavalieri S; Brai L Acta Eur Fertil; 1988; 19(3):159-65. PubMed ID: 3147563 [TBL] [Abstract][Full Text] [Related]
40. Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization-embryo transfer programs. Pinkas H; Orvieto R; Avrech OM; Rufas O; Ferber A; Ben-Rafael Z; Fisch B Gynecol Endocrinol; 2000 Feb; 14(1):11-4. PubMed ID: 10813101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]